secwatch.observer — SEC 8-K summary
======================================

Issuer:     FATE THERAPEUTICS INC (FATE)
CIK:        0001434316
Form:       8-K
Filed at:   2024-06-10T23:59:59+00:00
Accession:  0001193125-24-158374
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Fate Therapeutics stockholders approve charter amendment to exculpate officers
------------------------------------------------------------------------------

- Certificate of Amendment to Amended and Restated Certificate of Incorporation approved by stockholders at Annual Meeting on June 7, 2024.
- Amendment allows exculpation of certain officers, limiting personal liability for breaches of fiduciary duty.
- Effective upon filing with Delaware Secretary of State on June 7, 2024.
- Board recommended the amendment; stockholders voted to approve.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1434316/000119312524158374/0001193125-24-158374-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1434316/000119312524158374/d764437d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-158374

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer